Cancers · 2022 · 19 citations · 18 references
MedicineCancer BiologyOncologyMetastasisMolecular OncologySignal TransductionCancer Cell SignalingHepatocellular CarcinomaLiver CancerMalignant NeoplasmsOncogenic Signaling PathwaysSignal Transduction In CancerCancer Metastasis MechanismsCancer Signaling PathwaysEpithelial-mesenchymal Transition In CancerEpithelial-mesenchymal Transition MarkersHepatocellular Carcinoma MetastasisHepatocellular Carcinoma PathogenesisMesenchymal TransitionOncogenic Transformation
Hepatocellular carcinoma (HCC) is one of the major causes of cancer-related death worldwide. AHSA1 as a chaperone of HSP90 promotes the maturation, stability, and degradation of related cancer-promoting proteins. However, the regulatory mechanism and biological function of AHSA1 in HCC are largely unknown. Actually, we found that AHSA1 was significantly upregulated in HCC tissues and cell lines and was notably correlated with the poor clinical characteristics and prognosis of HCC patients in this study. Furthermore, both in vitro and in vivo, gain- and loss-of-function studies demonstrated that AHSA1 promoted the proliferation, invasion, metastasis, and epithelial-mesenchymal transition (EMT) of HCC. Moreover, the mechanistic study indicated that AHSA1 recruited ERK1/2 and promoted the phosphorylation and inactivation of CALD1, while ERK1/2 phosphorylation inhibitor SCH772984 reversed the role of AHSA1 in the proliferation and EMT of HCC. Furthermore, we demonstrated that the knockdown of CALD1 reversed the inhibition of proliferation and EMT by knocking AHSA1 in HCC. We also illustrated a new molecular mechanism associated with AHSA1 in HCC that was independent of HSP90 and MEK1/2. In summary, AHSA1 may play an oncogenic role in HCC by regulating ERK/CALD1 axis and may serve as a novel therapeutic target for HCC.
18
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang, Chenwei Li, Chenwei Li et al. · Nucleic Acids Research · 2017 · 10.6K citations · Full text
Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen et al. · The Lancet Oncology · 2008 · 5.8K citations
Medicine, Oncology, Pharmacotherapy +11
Gregor P. Lotz, Hongying Lin, Anja Harst et al. · Journal of Biological Chemistry · 2003 · 239 citations · Full text